==={{anchor|J06BC}}J06BC Antibacterial monoclonal antibodies===
==={{anchor|J06BD}}J06BD Antiviral monoclonal antibodies===
...
2 KB (248 words) - 17:18, 3 January 2023
* [[List of monoclonal antibodies]]
...
4 KB (491 words) - 12:41, 6 January 2023
* [[PCSK9]] inhibitors are [[monoclonal antibody|monoclonal antibodies]] for refractory cases. (e.g. [[Evolocumab]], [[Inclisiran]]) They are used
...
6 KB (772 words) - 10:25, 16 April 2024
* [[PCSK9]] inhibitors are [[monoclonal antibody|monoclonal antibodies]] for refractory cases. (e.g. [[Evolocumab]], [[Inclisiran]]) They are used
...
6 KB (794 words) - 10:24, 16 April 2024
...artment of Health and Human Services|米国保健福祉省]]は、RegeneronがCOVID-19と戦う[[:en:Monoclonal antibody|モノクローナル抗体]]を追求することを発表した。
[[Wikipedia:REGN-EB3|REGN-EB3]]は、致死性[[:en:ebola|エボラ]]ウイルスの治療を目的に開発された3つの[[:en:antibodies|抗体]]からなる医薬品です。2020年10月、米国食品医薬品局（FDA）は、ザイールのエボラウイルスによる感染症の治療薬として、[[:en:atolt
...
11 KB (424 words) - 13:13, 3 January 2024
{{Short description|Antibodies from clones of the same blood cell}}
...elboin HV, Krausz KW, Gonzalez FJ, Yang TJ | title = Inhibitory monoclonal antibodies to human cytochrome P450 enzymes: a new avenue for drug discovery | journal
...
44 KB (5,708 words) - 17:44, 3 January 2023
* [[Antibody|Antibodies]] for [[passive immunity]] (e.g., to treat a [[virus]] infection)
...the body, or to target any specific cell type; examples of such monoclonal antibodies for use in various diseases are given in the table below.
...
29 KB (3,642 words) - 16:31, 3 January 2023
...tions for more than 50 biosimilars since 2006. The first biosimilar of a [[monoclonal antibody]] to be approved worldwide was a biosimilar of [[infliximab]] in t
...ant DNA]] based biological substance for eventual development of a drug. [[Monoclonal antibody]] technology combined with recombinant DNA technology has paved th
...
21 KB (2,692 words) - 09:55, 20 March 2024
| -mab || [[Monoclonal antibodies]]<ref name=AMA/> || [[trastuzumab]], [[ipilimumab]]
...n antibodies (to reduce the likelihood of the patient developing their own antibodies against the therapeutic antibody) <ref name = AMA/> || [[infliximab]]
...
25 KB (3,297 words) - 17:05, 3 January 2023
...tions for more than 50 biosimilars since 2006. The first biosimilar of a [[monoclonal antibody]] to be approved worldwide was a biosimilar of [[infliximab]] in t
...ant DNA]] based biological substance for eventual development of a drug. [[Monoclonal antibody]] technology combined with recombinant DNA technology has paved th
...
21 KB (2,770 words) - 09:54, 20 March 2024
* {{cite journal | vauthors = Gelboin HV, Krausz K | title = Monoclonal antibodies and multifunctional cytochrome P450: drug metabolism as paradigm | journal
...elboin HV, Krausz KW, Gonzalez FJ, Yang TJ | title = Inhibitory monoclonal antibodies to human cytochrome P450 enzymes: a new avenue for drug discovery | journal
...
49 KB (2,511 words) - 09:28, 17 March 2024
...oduct]]s). With the exception of [[Monoclonal antibody therapy|therapeutic antibodies]], many proteins are degraded if administered orally and most often cannot
...ted, which can be done by adding to the [[Growth medium|media]] anti-shh [[antibodies]], [[HHIP|Hedgehog interacting protein]], or [[cyclopamine]], where the fir
...
11 KB (1,440 words) - 16:29, 3 January 2023
...d via subcutaneous injection or infusion include [[insulin]], [[monoclonal antibodies]], and [[heparin]]. These medications cannot be administered orally as the
...-list-style = vanc | doi-access = free }}</ref> as well as many monoclonal antibodies. In most cases, injection site reactions are self-limiting and resolve on t
...
22 KB (2,885 words) - 17:22, 3 January 2023
* {{cite journal | vauthors = Gelboin HV, Krausz K | title = Monoclonal antibodies and multifunctional cytochrome P450: drug metabolism as paradigm | journal
...elboin HV, Krausz KW, Gonzalez FJ, Yang TJ | title = Inhibitory monoclonal antibodies to human cytochrome P450 enzymes: a new avenue for drug discovery | journal
...
38 KB (5,401 words) - 20:37, 15 March 2024
* {{cite journal | vauthors = Gelboin HV, Krausz K | title = Monoclonal antibodies and multifunctional cytochrome P450: drug metabolism as paradigm | journal
...elboin HV, Krausz KW, Gonzalez FJ, Yang TJ | title = Inhibitory monoclonal antibodies to human cytochrome P450 enzymes: a new avenue for drug discovery | journal
...
39 KB (5,513 words) - 20:35, 15 March 2024
PCSK9 inhibitors are monoclonal antibodies that target an important protein in the degradation of LDL called proprotei
...
15 KB (2,054 words) - 17:52, 13 April 2024
PCSK9 inhibitors are monoclonal antibodies that target an important protein in the degradation of LDL called proprotei
...
16 KB (2,114 words) - 17:52, 13 April 2024
****** by [[monoclonal antibody|monoclonal antibodies]]: [[monoclonal antibody therapy]]
...
31 KB (4,067 words) - 16:45, 3 January 2023
...G|IVIG]]), [[gene therapy|gene therapy]], [[Monoclonal antibody|monoclonal antibodies]] and [[cell therapy|cell therapy]] (for instance, [[stem cell|stem cell]]
...ppressant]]s, [[interferon|interferon]]s, [[monoclonal antibody|monoclonal antibodies]].
...
52 KB (6,923 words) - 17:09, 5 November 2023
...G|IVIG]]), [[gene therapy|gene therapy]], [[Monoclonal antibody|monoclonal antibodies]] and [[cell therapy|cell therapy]] (for instance, [[stem cell|stem cell]]
...ppressant]]s, [[interferon|interferon]]s, [[monoclonal antibody|monoclonal antibodies]].
...
54 KB (7,245 words) - 17:08, 5 November 2023